Filtered By:
Management: Health Insurance
Vaccination: Influenza Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 112 results found since Jan 2013.
Once vaccinated, always vaccinated? A claims data analysis on repeated influenza vaccinations among individuals aged ≥ 60 years
DISCUSSION: A large proportion of individuals aged ≥ 60 years who have been vaccinated against influenza once is likely to repeatedly receive vaccinations. In accordance with vaccination recommendations, nursing home residents and in particular individuals with an increased health risk are vaccinated repeatedly. General practitioners play a central role: non-acute patient contacts should be used to offer vaccinations, especially to women and individuals in need of care who are living at home.PMID:37291252 | DOI:10.1007/s00103-023-03716-1
Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - June 8, 2023 Category: International Medicine & Public Health Authors: Josephine Storch Franziska Meissner Monique B öde Anja Kwetkat Mathias W Pletz Antje Freytag Source Type: research
Predictors of COVID-19 vaccine uptake among people who inject drugs
CONCLUSIONS: One year after COVID-19 vaccines became available to U.S. adults, only one third of PWID had received ≥1 COVID-19 vaccine dose. Multi-faceted approaches that dispel disinformation, integrate public health and social services and increase access to free, community-based COVID-19 vaccines are urgently needed.PMID:36697311 | DOI:10.1016/j.vaccine.2023.01.042
Source: Vaccine - January 25, 2023 Category: Allergy & Immunology Authors: Steffanie A Strathdee Daniela Abramovitz Carlos F Vera Irina Artamonova Thomas L Patterson Davey M Smith Antoine Chaillon Angela R Bazzi Source Type: research
Risk of Guillain-Barr é Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan
CONCLUSIONS AND RELEVANCE: These findings suggest that influenza vaccination did not increase the risk of GBS among adults aged 65 years or older in Taiwan regardless of postvaccination period or underlying characteristics.PMID:36129709 | DOI:10.1001/jamanetworkopen.2022.32571
Source: Cancer Control - September 21, 2022 Category: Cancer & Oncology Authors: Cheng-Chang Yen Kai-Che Wei Wen-Hwa Wang Yu-Tung Huang Yu-Chia Chang Source Type: research
Influenza vaccine and subsequent development of zoster
CONCLUSIONS: There was a slight increase in risk of HZ in people receiving influenza vaccine in the first 1-15 days after vaccination.PMID:36114790 | DOI:10.1111/irv.13055
Source: Herpes - September 17, 2022 Category: Infectious Diseases Authors: Kai-Che Wei Yu-Chia Chang Yu-Tung Huang Source Type: research
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study
CONCLUSION: Pneumococcal and influenza vaccination coverage of adults at risk of pneumococcal disease fell well below public health expectations. Invitations for pneumococcal vaccination should be sent by the NHI to high-risk patients. Patient management protocols should include pneumococcal vaccination. Patients with multiple comorbidities are a high-priority population given the large potential health gains offered by pneumococcal vaccination. Commitment of both scientific societies and health authorities is urgently needed to increase vaccination coverage in at-risk populations.PMID:35811205 | DOI:10.1016/j.vaccine.2022.06.071
Source: Vaccine - July 10, 2022 Category: Allergy & Immunology Authors: Benjamin Wyplosz J érôme Fernandes Ariane Sultan Nicolas Roche Fran çois Roubille Paul Loubet Bertrand Foug ère Bruno Moulin Didier Duhot Alexandre Vainchtock Fanny Raguideau Joannie Lortet-Tieulent Emmanuelle Blanc Jennifer Mo ïsi Gwena ël Goussiau Source Type: research
Trust in the public health system as a source of information on vaccination matters most when environments are supportive
CONCLUSIONS: Environmental factors supportive of vaccination increased the positive influence of trust in CDC on vaccine uptake by almost 50 percent. Insurance companies and healthcare providers can promote vaccination by covering the costs of vaccination and discussing vaccines in personalized conversations with patients.PMID:35753840 | DOI:10.1016/j.vaccine.2022.06.012
Source: Vaccine - June 26, 2022 Category: Allergy & Immunology Authors: Sophie Lohmann Dolores Albarrac ín Source Type: research
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans
Vaccine. 2022 May 20:S0264-410X(22)00615-6. doi: 10.1016/j.vaccine.2022.05.031. Online ahead of print.ABSTRACTDespite wide availability, only 50.2% of the United States (US) adult population and 50.3% of adult Arkansans were vaccinated for influenza during the 2020-2021 influenza season. The proportion of the population vaccinated for influenza varies by age, sex, race/ethnicity, education, rural/urban residence, and income. However, measures of healthcare access have not been adequately investigated as predictors of influenza vaccination. Using a large, statewide random sample, this study examined 5-year influenza vaccina...
Source: Vaccine - May 23, 2022 Category: Allergy & Immunology Authors: Pearl A McElfish James P Selig Aaron J Scott Brett Rowland Don E Willis Sharon Reece Sheena CarlLee Morgan Gurel-Headley Sumit K Shah Michael D Macechko Source Type: research
